Olin rises 9.7% after mixed third-quarter results and merger progress

What happened

Olin (OLN) rose 9.7% on October 30, 2026, because of third-quarter results and a merger update that accompanied the earnings release. The company reported third-quarter net income of $14.4 million, or $0.13 per diluted share, and quarterly adjusted EBITDA of $191.4 million. Analysts' coverage and the full earnings call transcript were published alongside the results, according to Seeking Alpha and Zacks Investment Research. The company also said it has made substantial progress toward completing a planned merger with Huntsman and expects the deal in the first quarter of 2027 after clearing required U.S. antitrust review and securing approvals in several jurisdictions, while regulatory reviews continue in Europe, China and other regions, MarketBeat and PRNewsWire reported.

How big was the move

The stock rose 9.7% on the session, a move that was 4.0 times a typical daily move for this stock and 10.2 percentage points better than the Basic Materials sector median on the day. Trading volume was 1.3 times its 20-day average, and the stock opened 1.1% above the previous close. The S&P 500 fell 1.8% on the day and the Basic Materials sector median fell 0.6%, so Olin's gain stood out relative to both the market and its sector. The stock's beta of 0.90 suggests it tends to move less than the market, making a near 10% rise notable amid a broadly weaker tape.

The technical picture

At the close the stock was 12.2% above its 20-day moving average and 7.1% above its 50-day moving average, while it remained 21.2% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 65, which sits between 30 and 70, a neutral range. The stock is 42.2% below its 52-week high, has risen 10.3% over one month, fallen 5.5% over three months and fallen 17.7% over one year, which is 27.7 percentage points behind the S&P 500. Volatility was 38% annualized over 60 days, lower than 65% of its own readings over five years, suggesting recent swings have been muted relative to its historical norms.

Fundamentals and valuation

For the four quarters through September 30, 2026, Olin reported revenue of $6.74 billion, a decline of 0.7% from a year earlier, and diluted earnings per share of $-1.47, which represented a fall of 418.3% from a year earlier. Gross margin narrowed to 6.7% from 9.3% a year earlier, and operating margin slid to 0.4% from 1.9%. Free-cash-flow margin stood at 2.3% and return on invested capital was 1.0%, pointing to weak profitability and limited returns on deployed capital.

The balance sheet showed net debt of 7.3 times EBITDA, a leverage metric that investors often watch closely in cyclical chemical businesses. Share count over one year decreased by 0.5%, and the company's free-cash-flow yield was 8.5%. Those valuation and capital-return metrics sit alongside PromtFinance sector scores that rate Olin positively for Value at 77, but very weak for Growth, Quality, Momentum, Revisions and Stability, underscoring a contrast between a seemingly attractive yield and weaker operating performance.

Earnings and analyst expectations

Olin's last report, on October 29, 2026, showed earnings per share of $0.13 against $0.15 expected, 11.6% below estimates. The company has zero consecutive quarters beating estimates, and the average surprise over the last four reports was 0.2% above estimates. Historically the typical two-day reaction after recent reports was that the stock fell 1.9%, so the market's strong positive response this session reflected either relief on the merger progress or investors focusing on short-term technicals and volume.

Analysts' consensus price target is $19.22, which is 9.2% above the closing price, based on the ratings of 35 analysts; 29% of those analysts rate the stock Buy or Strong Buy and the consensus rating is Hold. The next report is scheduled for January 28, 2027.

What to watch

• October 29, 2026: last report showed earnings per share of $0.13 against $0.15 expected, 11.6% below estimates
• First quarter of 2027: company expects to complete planned merger with Huntsman after clearing required U.S. antitrust review and securing approvals in several jurisdictions
• January 28, 2027: next scheduled earnings report
• Balance sheet metric: net debt of 7.3 times EBITDA
• Valuation metric: free-cash-flow yield of 8.5%